Skip to content

Mobile Coach for Parents of Children and Adolescents With Chronic Pain

Mobile Coach for Parents of Children and Adolescents With Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03356275
Enrollment
34
Registered
2017-11-29
Start date
2017-12-18
Completion date
2018-03-13
Last updated
2018-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Parents, Pediatric Disorder

Brief summary

Chronic pain is estimated to affect 20% to 35% of children and adolescents around the world, and is associated with increased risk of anxiety and depression among children and adolescents, as well as coping challenges, anxiety, depression, and anger in their parents. For parents, learning to manage stress is critical, as parents play a significant role in a child's experience of pain. Parental behaviors such as over-involvement, solicitousness and rejection are associated with decreased functioning, including higher school absenteeism in children and teens. A number of interventions demonstrate that teaching skills to parents can have a direct and positive impact on the health of children and adolescents with chronic pain. The investigators propose to create and test the BodiMojo Parent Buddy which will provide parents with real-time, tailored and adaptive coping and stress management support and will provide a curriculum of skills for responding to a child in pain in order to promote child functioning. Thirty parents of children ages 8-18 who have been diagnosed with a non-cancer chronic pain condition will participate in this user-testing study. Parents will complete a brief set of questionnaires before and after the intervention, and will be instructed to open and use the app each day for 30 days. Participants will complete audio mindfulness exercises, watch brief video clips, and read psychoeducational information about pain, coping, and communication skills. Post-intervention questionnaires will also include an acceptance test to assess participants' opinions about the helpfulness and usability of the app. Parent participation is expected to take around 3.5 hours total over the 30 day study period.

Interventions

BEHAVIORALMindfulness for Resilience in Illness: Support for Parents

Mobile application focusing on emotional coping skills for parents of children and adolescents with chronic pain. Components of the module include: library of mindfulness meditations/relaxations; peer support videos; and psychoeducational information related to pain, stress, and mindfulness.

Sponsors

BodiMojo, Inc.
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Parents who self-report parenting a child or adolescent ages 8-18 with non-cancer chronic pain. * Daily use of a smartphone (iOS, Android, or Windows) or tablet. * Ability to speak and understand English.

Exclusion criteria

* Inability to provide consent * Inability to speak and understand English

Design outcomes

Primary

MeasureTime frameDescription
Ratio of the days during the 30-day intervention period during which participants use the appAt the conclusion of the final day of the intervention (Day 30)Determined by how often participants engaged and used certain features. To be considered feasible, participants must have opened the app on at least half of the days.
AcceptanceWithin 7 days of competing the interventionDetermined by participants' responses to acceptance test questions in the following domains: (1) how much the participant liked the various app features; (2) how much participants liked the video and supplementary content; and (3) helpfulness of various app features. Responses will be given on a one to seven-point-scale ranging terrible to excellent. The intervention will be deemed acceptable if at least 80% of participants rate each question an average of at least 5 (good) on the 7-point scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026